Bluestone Jeffrey bought GILD
August 20, 2026 · Form 4 insider transaction
Bluestone Jeffrey bought 26 shares of Gilead Sciences, Inc. at $67.45 per share, a transaction worth $1.8K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
26
Price
$67.45
Total value
$1.8K
InsiderBluestone Jeffrey
Role—
CompanyGilead Sciences, Inc. (GILD)
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateAugust 20, 2026
Filing dateAugust 21, 2026
Shares owned after10,092
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on May 20, 2026.